Jov-CMDF

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Nov 1, 2007	Ambit Biosciences	$49.0M Series D	—	OrbiMed, Allan Marchington, Avalon Ventures, Standish Fleming, Genechem, Gimv, Horizon Technology Finance, David Mott, NovaQuest Capital Management, Perseus-Soros Biopharmaceutical Fund, Radius Ventures, Roche

Total Raised

N/A

Valuation

N/A